p.169 抽出テキスト
180-231. PMID: 35315610 514. Matharu GS, Kunutsor SK, Judge A, et al. Clinical effectiveness and safety of aspirin for venous thromboembolism prophylaxis after total hip and knee replacement: A systematic review and meta-analysis of randomized clinical trials. JAMA Intern Med 2020; 180: 376- 384. PMID: 32011647 515. Glotzbecker MP, Bono CM, Wood KB, et al. Thromboembolic disease in spinal surgery: a systematic review. Spine (Phila Pa 1976) 2009; 34: 291-303. PMID: 19179925 516. Turpie AG, Hirsh J, Gent M, et al. Prevention of deep vein thrombosis in potential neurosurgical patients. A randomized trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression with control. Arch Intern Med 1989; 149: 679-681. PMID: 2645846 517. Samama CM, Afshari A. ESA VTE Guidelines Task Force. European guidelines on perioperative venous thromboembolism prophylaxis. Eur J Anaesthesiol 2018; 35: 73-76. PMID: 29112552 518. Collen JF, Jackson JL, Shorr AF, et al. Prevention of venous thromboembolism in neurosurgery: a metaanalysis. Chest 2008; 134: 237- 249. PMID: 18641095 519. Wang X, Zhou YC, Zhu WD, et al. The risk of postoperative hemorrhage and efficacy of heparin for preventing deep vein thrombosis and pulmonary embolism in adult patients undergoing neurosurgery: a systematic review and meta-analysis. J Investig Med 2017; 65: 1136-1146. PMID: 28747317 520. Gibson CM, Spyropoulos AC, Cohen AT, et al. The IMPROVEDD VTE risk score: Incorporation of D-dimer into the IMPROVE score to improve venous thromboembolism risk stratification. TH Open 2017; 1: e56-e65. PMID: 31249911 521. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003; 107 Suppl: I9-I16. PMID: 12814980 522. 荻原義人.CQ9:静脈血栓塞栓症の予防に圧迫療法は有用か?: 6.内科領域(脳卒中後含む).日本静脈学会 監修.圧迫療法ガイドライン小委員会 編.静脈疾患における圧迫療法ガイドライン2025.日本医事新報社 2025:95-103. 523. 日本版敗血症診療ガイドライン2020特別委員会(日本集中治療医学会,日本救急医学会).日本版敗血症診療ガイドライン2020 (J-SSCG2020).https://www.jsicm.org/pdf/jjsicm28Suppl.pdf 524. Kamphuisen PW, Agnelli G. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke? Thromb Res 2007; 119: 265-274. PMID: 16674999 525. Dennis M, Caso V, Kappelle LJ, et al. European Stroke Organisation. European Stroke Organisation (ESO) guidelines for prophylaxis for venous thromboembolism in immobile patients with acute ischaemic stroke. Eur Stroke J 2016; 1: 6-19. PMID: 31008263 526. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2019; 50: e344-e418. PMID: 31662037 527. Kierkegaard A, Norgren L. Graduated compression stockings in the prevention of deep vein thrombosis in patients with acute myocardial infarction. Eur Heart J 1993; 14: 1365-1368. PMID: 8262083 528. Kahale LA, Matar CF, Tsolakian I, et al. Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation. Cochrane Database Syst Rev 2021; 10: CD006466. PMID: 34622445 529. Rutjes AW, Porreca E, Candeloro M, et al. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Cochrane Database Syst Rev 2020; 12: CD008500. PMID: 33337539 530. Carrier M, Abou-Nassar K, Mallick R, et al. AVERT Investigators. Apixaban to prevent venous thromboembolism in patients with cancer. N Engl J Med 2019; 380: 711-719. PMID: 30511879 531. Khorana AA, Soff GA, Kakkar AK, et al. CASSINI Investigators. Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer. N Engl J Med 2019; 380: 720-728. PMID: 30786186 532. Bosch FTM, Mulder FI, Kamphuisen PW, et al. Primary thromboprophylaxis in ambulatory cancer patients with a high Khorana score: a systematic review and meta-analysis. Blood Adv 2020; 4: 5215-5225. PMID: 33104795 533. Macbeth F, Noble S, Evans J, et al. Randomized phase III trial of standard therapy plus low molecular weight heparin in patients with lung cancer: FRAGMATIC Trial. J Clin Oncol 2016; 34: 488-494. PMID: 26700124 534. Pelzer U, Opitz B, Deutschinoff G, et al. Efficacy of prophylactic low-molecular weight heparin for ambulatory patients with ad- vanced pancreatic cancer: Outcomes from the CONKO-004 Trial. J Clin Oncol 2015; 33: 2028-2034. PMID: 25987694 535. Schünemann HJ, Ventresca M, Crowther M, et al. Evaluating pro- phylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis. Lancet Haematol 2020; 7: e746-e755. PMID: 32976752 536. Li A, Kuderer NM, Garcia DA, et al. Direct oral anticoagulant for the prevention of thrombosis in ambulatory patients with cancer: A systematic review and meta-analysis. J Thromb Haemost 2019; 17: 2141-2151. PMID: 31420937 537. Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999; 341: 793-800. PMID: 10477777 538. Leizorovicz A, Cohen AT, Turpie AG, et al. PREVENT Medical Thromboprophylaxis Study Group. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004; 110: 874-879. PMID: 15289368 539. Cohen AT, Davidson BL, Gallus AS, et al. ARTEMIS Investigators. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ 2006; 332: 325-329. PMID: 16439370 540. Mahan CE, Fisher MD, Mills RM, et al. Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population. Thromb Res 2013; 132: 520-526. PMID: 24080150 541. Hull RD, Merali T, Mills A, et al. Venous thromboembolism in elderly high-risk medical patients: time course of events and influence of risk factors. Clin Appl Thromb Hemost 2013; 19: 357-362. PMID: 23610237 542. Amin AN, Varker H, Princic N, et al. Duration of venous thromboembolism risk across a continuum in medically ill hospitalized patients. J Hosp Med 2012; 7: 231-238. PMID: 22190427 543. Alshouimi RA, Al Rammah SM, Alzahrani MY, et al. The use of direct oral anticoagulants for extended duration thromboprophylaxis in medically ill patients: a systematic review and meta-analysis. J Thromb Thrombolysis 2019; 48: 422-429. PMID: 31222563 544. Chi G, Yee MK, Amin AN, et al. Extended-duration betrixaban reduces the risk of rehospitalization associated with venous thromboembolism among acutely ill hospitalized medical patients: Findings from the APEX Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial). Circulation 2018; 137: 91-94. PMID: 29279341 545. Cohen AT, Spiro TE, Büller HR, et al. MAGELLAN Investigators. Rivaroxaban for thromboprophylaxis in acutely ill medical patients. N Engl J Med 2013; 368: 513-523. PMID: 23388003 546. Bhalla V, Lamping OF, Abdel-Latif A, et al. Contemporary meta-analysis of extended direct-acting oral anticoagulant thromboprophylaxis to prevent venous thromboembolism. Am J Med 2020; 133: 1074-1081. PMID: 32151593 547. Schünemann HJ, Cushman M, Burnett AE, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv 2018; 2: 3198-3225. PMID: 30482763 548. National Institute for Health and Care Excellence (NICE). Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. NICE guideline [NG89] (Last updated: 13 August 2019). 549. Arabi YM, Al-Hameed F, Burns KEA, et al. Saudi Critical Care Trials Group. Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. N Engl J Med 2019; 380: 1305-1315. PMID: 30779530 550. Shalhoub J, Lawton R, Hudson J, et al. GAPS trial investigators. Graduated compression stockings as adjuvant to pharmaco-thromboprophylaxis in elective surgical patients (GAPS study): randomised controlled trial. BMJ 2020; 369: m1309. PMID: 32404430 551. Cohen AT, Skinner JA, Warwick D, et al. The use of graduated compression stockings in association with fondaparinux in surgery of the hip. A multicentre, multinational, randomised, open-label, parallel-group comparative study. J Bone Joint Surg Br 2007; 89: 887- 892. PMID: 17673580 552. Vignon P, Dequin PF, Renault A, et al. Clinical Research in Intensive Care and Sepsis Group (CRICS Group). Intermittent pneumatic compression to prevent venous thromboembolism in patients with high risk of bleeding hospitalized in intensive care units: the CIREA1 randomized trial. Intensive Care Med 2013; 39: 872-880. PMID: 23370827 553. Haykal T, Zayed Y, Dhillon H, et al. Meta-analysis of the role of in- termittent pneumatic compression of the lower limbs to prevent ve-